Schnack Tine H, Høgdall Estrid, Thomsen Lotte Nedergaard, Høgdall Claus
*Juliane Marie Centret, Gynaecological Clinic, University Hospital of Copenhagen, København Ø; †Department of Pathology, Molecular Unit, Herlev Hospital, Herlev; and ‡Department of Pathology, University Hospital of Copenhagen, København Ø, Denmark.
Int J Gynecol Cancer. 2017 Nov;27(9):1804-1812. doi: 10.1097/IGC.0000000000001102.
Women with endometriosis carry an increased risk for ovarian clear cell adenocarcinomas (CCCs). Clear cell adenocarcinoma may develop from endometriosis lesions. Few studies have compared clinical and prognostic factors and overall survival in patients diagnosed as having CCC according to endometriosis status.
Population-based prospectively collected data on CCC with coexisting pelvic (including ovarian; n = 80) and ovarian (n = 46) endometriosis or without endometriosis (n = 95) were obtained through the Danish Gynecological Cancer Database. χ Test, independent-samples t test, logistic regression, Kaplan-Meier test, and Cox regression were used. Statistical tests were 2 sided. P values less than 0.05 were considered statistically significant.
Patients with CCC and pelvic or ovarian endometriosis were significantly younger than CCC patients without endometriosis, and a higher proportion of them were nulliparous (28% and 31% vs 17% (P = 0.07 and P = 0.09). Accordingly, a significantly higher proportion of women without endometriosis had given birth to more than 1 child. Interestingly, a significantly higher proportion of patients with ovarian endometriosis had pure CCCs (97.8% vs 82.1%; P = 0.001) as compared with patients without endometriosis. Overall survival was poorer among CCC patients with concomitant ovarian endometriosis (hazard ratio, 2.56 [95% confidence interval, 1.29-5.02], in the multivariate analysis.
Age at CCC diagnosis and parity as well as histology differ between CCC patients with and without concomitant endometriosis. Furthermore, CCC patients with concomitant ovarian endometriosis have a poorer prognosis compared with endometriosis-negative CCC patients. These differences warrant further research to determine whether CCCs with and without concomitant endometriosis develop through distinct pathogenic pathways.
患有子宫内膜异位症的女性患卵巢透明细胞腺癌(CCC)的风险增加。透明细胞腺癌可能由子宫内膜异位症病变发展而来。很少有研究比较根据子宫内膜异位症状态诊断为CCC的患者的临床和预后因素及总生存期。
通过丹麦妇科癌症数据库获得基于人群的前瞻性收集的关于伴有盆腔(包括卵巢;n = 80)和卵巢(n = 46)子宫内膜异位症或无子宫内膜异位症(n = 95)的CCC数据。采用χ检验、独立样本t检验、逻辑回归、Kaplan-Meier检验和Cox回归。统计检验为双侧检验。P值小于0.05被认为具有统计学意义。
患有CCC且伴有盆腔或卵巢子宫内膜异位症的患者比无子宫内膜异位症的CCC患者明显年轻,且未生育的比例更高(分别为28%和31%,而无子宫内膜异位症的患者为其中的17%,P = 0.07和P = 0.09)。相应地,无子宫内膜异位症的女性生育超过1个孩子的比例明显更高。有趣的是,与无子宫内膜异位症的患者相比,患有卵巢子宫内膜异位症的患者中纯CCC的比例明显更高(97.8%对82.1%;P = 0.001)。在多变量分析中,伴有卵巢子宫内膜异位症的CCC患者的总生存期较差(风险比,2.56 [95%置信区间,1.29 - 5.02])。
伴有和不伴有子宫内膜异位症的CCC患者在CCC诊断时的年龄、生育情况以及组织学方面存在差异。此外,与无子宫内膜异位症的CCC患者相比,伴有卵巢子宫内膜异位症的CCC患者预后较差。这些差异值得进一步研究,以确定伴有和不伴有子宫内膜异位症的CCC是否通过不同的致病途径发展而来。